About 60% of MSS patients carry homozygous or compound heterozygous mutations in the SIL1 gene that make the SIL1 protein unstable, eventually leading to its loss [2,6,7,8]. The gene discussed is SIL1; the disease is Marinesco-Sjogren syndrome.